Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 205Recruiting 69Terminated 59Active not recruiting 59Unknown 50Withdrawn 21Not yet recruiting 12Enrolling by invitation 2Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 22Lymphoid 10Thoracic 9CNS 9Other hematologic neoplasm 8Genitourinary 8Sarcoma 7Head & Neck 5Dermatologic 5Breast 5Gynecologic 4Tumor-Agnostic 2Plasma cell 2Other solid neoplasm 2Myeloid 2Endocrine 1

Conditions

Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Mesothelioma, Malignant 1Hodgkin Disease 1Carcinoma, Neuroendocrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Suspended × Endocrine × Clear all
NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

M.D. Anderson Cancer Center

Phase 2 Suspended
140 enrolled
EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡